Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
New approach to determine the healthy immune variations by combining clustering methods.
Sci Rep. 2021 Apr 26;11(1):8917. doi: 10.1038/s41598-021-88272-x.
Sci Rep. 2021.
PMID: 33903641
Free PMC article.
Clinical Trial.
Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance.
Liefferinckx C, Minsart C, Toubeau JF, Cremer A, Amininejad L, Quertinmont E, Devière J, Gils A, van Gossum A, Franchimont D.
Liefferinckx C, et al. Among authors: toubeau jf.
Inflamm Bowel Dis. 2017 Aug;23(8):1371-1381. doi: 10.1097/MIB.0000000000001120.
Inflamm Bowel Dis. 2017.
PMID: 28498153
Item in Clipboard
Predictive models assessing the response to ustekinumab highlight the value of therapeutic drug monitoring in Crohn's disease.
Liefferinckx C, Hubert A, Thomas D, Bottieau J, Minsart C, Cremer A, Amininejad L, Vallée F, Toubeau JF, Franchimont D.
Liefferinckx C, et al. Among authors: toubeau jf.
Dig Liver Dis. 2023 Mar;55(3):366-372. doi: 10.1016/j.dld.2022.07.015. Epub 2022 Aug 14.
Dig Liver Dis. 2023.
PMID: 35977875
Item in Clipboard
Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases.
Liefferinckx C, Bottieau J, Toubeau JF, Thomas D, Rahier JF, Louis E, Baert F, Dewint P, Pouillon L, Lambrecht G, Vallée F, Vermeire S, Bossuyt P, Franchimont D.
Liefferinckx C, et al. Among authors: toubeau jf.
Inflamm Bowel Dis. 2022 Feb 1;28(2):208-217. doi: 10.1093/ibd/izab042.
Inflamm Bowel Dis. 2022.
PMID: 33783494
Item in Clipboard
Cite
Cite